Shows PC supplementation improves lipid balance in CERKL-deficient retinitis pigmentosa, suggesting a metabolic intervention.
Our work establishes dysregulated PC metabolism due to PCYT1A hypophosphorylation as a pathogenic driver in CERKL-deficient RP. We identify PC supplementation as a readily translatable, metabolic therapy for this genetically defined form of retinal degeneration.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: